← All organizations

Senhwa Biosciences, Inc.

For profit

Also known as: Chris Recknor, MD | Senhwa Biosciences | Senhwa Biosciences, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Feb 27, 2024

Timeline

2010s

Jun 1, 2013
Senhwa Biosciences, Inc.— Founded

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06202521Lead sponsorPhase 2Feb 27, 2024
NCT06202521OfficialPhase 2Feb 27, 2024
NCT05817708Lead sponsorPhase 1Nov 7, 2022
NCT04890613Study directorPhase 1Sep 8, 2021
NCT04890613Lead sponsorPhase 1Sep 8, 2021
NCT04668209CollaboratorPhase 2Dec 15, 2020
NCT04663737Lead sponsorPhase 2Dec 3, 2020
NCT04663737Sponsor investigatorPhase 2Dec 3, 2020
NCT03897036Lead sponsorPhase 1Apr 1, 2019
NCT03897036Study directorPhase 1Apr 1, 2019
NCT02719977CollaboratorPhase 1/Phase 2May 16, 2016
NCT02128282Lead sponsorPhase 1/Phase 2Jun 1, 2014

Details

Founded: San Diego, CA, US Jun 1, 2013
Last known activity: Feb 27, 2024